✦ LIBER ✦

High-dose tirofiban vs abciximab in acute STEMI patients undergoing primary percutaneous coronary intervention

✍ Scribed by Mohammed A. Balghith; Sharif Zain; Omaimah Alaomary

Book ID: 113515965
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 73 KB
Volume: 10
Category: Article
ISSN: 1553-8389
DOI: 10.1016/j.carrev.2009.04.074

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparison of abciximab with “high-dose”

Comparison of abciximab with “high-dose” tirofiban in patients undergoing percutaneous coronary intervention

✍ Athula P. Gunasekara; Darren L. Walters; Con N. Aroney 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 109 KB

Prehospital high-dose tirofiban in patie

Prehospital high-dose tirofiban in patients undergoing primary percutaneous intervention. The AGIR-2 study

✍ Carlos El Khoury; Pierre-Yves Dubien; Catherine Mercier; Loic Belle; Guilaume De 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 545 KB

Inhibition of platelet function by abcix

Inhibition of platelet function by abciximab or high-dose tirofiban in patients with STEMI undergoing primary PCI: a randomised trial

✍ J. W. van Werkum; W. B. M. Gerritsen; J. C. Kelder; C. M. Hackeng; S. M. Ernst; 📂 Article 📅 2007 🏛 Bohn Stafleu van Loghum 🌐 English ⚖ 164 KB

Comparison of efficacy and safety of nat

Comparison of efficacy and safety of native eptifibatide vs. tirofiban in patients with acute coronary syndrome undergoing percutaneous coronary intervention

✍ Jianjin Tang; Liansheng Wang; Hui Wang; Mingwei Wang; Kejiang Cao; Zhijian Yang 📂 Article 📅 2008 🏛 Chinese Electronic Periodical Services 🌐 English ⚖ 132 KB

Intracoronary versus intravenous high-do

Intracoronary versus intravenous high-dose bolus plus maintenance administration of tirofiban in patients undergoing primary percutaneous coronary intervention for acute ST elevation myocardial infarction

✍ Basar Candemir, Mustafa Kilickap, Ozgur Ulas Ozcan, Cansin Tulunay Kaya, Menekse 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 197 KB

A Trial of Early Inhibition of Platelet

A Trial of Early Inhibition of Platelet Aggregation in Patients with Acute Coronary Syndrome (ACS) Undergoing Percutaneous Intervention (PCI): High Dose Tirofiban Bolus and Infusion Compared to Standard Dose Abciximab

✍ C.C.S. Lim; B. Chou; L. Roberts; V. Pandeli; A. Teh; Y.M. Cheong; C. Goods; M. R 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 86 KB